| 1 |
10541377 | Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas. | 1999 Oct |
2 |
| 2 |
9191878 | Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22. | 1997 May |
2 |
| 3 |
7493367 | Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. | 1995 Dec 1 |
1 |
| 4 |
1536812 | Haematological effects of radioimmunotherapy in cancer patients. | 1992 Jan |
2 |